Klinikum Ludwigshafen

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Coronary artery disease1 trial
• Diffuse large B-cell lymphoma1 trial
• Mantle cell lymphoma1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Helios Health Institute GmbH1 trial
• Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 trial
• Karyopharm Therapeutics Inc1 trial
• The Lymphoma Academic Research Organisation1 trial

Running trials

• Active, not recruiting

  Remote Ischemic Conditioning With Local Ischemic Postconditioning in High-Risk ST-elevation Myocardial Infarction

  NCT04844931· Helios Health Institute GmbH· Source

• Active, not recruiting

  Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

  NCT02227251· Phase 2· Karyopharm Therapeutics Inc· Source

Closed trials

• Completed

  Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer

  NCT03530267· Phase 2· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Source

• Completed

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· Phase 3· The Lymphoma Academic Research Organisation· Source